Cargando…
The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state
An antidiabetic drug, rosiglitazone is a member of the drug class of thiazolidinedione. Although restrictions on use due to the possibility of heart toxicity have been removed, it is still a drug that is concerned about side effects on the heart. We here examined, using Chinese hamster ovary cells,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890944/ https://www.ncbi.nlm.nih.gov/pubmed/35203063 http://dx.doi.org/10.4196/kjpp.2022.26.2.135 |